News

Clinical Pharmacy Services (including Pharmacy First)

NHS Scotland allows patients to use a community pharmacy as their first point of contact to receive a range of Health Board, Public Health and Pandemic services on the NHS. A range of services are available including emergency contraception, smoking cessation and gluten-free food dispensing. The Clinical Pharmacy Services (CPS) module of ProScript Connect enables […]

Pharmacy First Rejected Items

Pharmacy First Rejected Items  Community Pharmacy Scotland (CPS) have recently communicated an increased number of disallowed items for the NHS Pharmacy First Scotland service resulting in claims for these items rejected for reimbursement. The majority of these rejections were due to a technical issue and further information can be found on the CPS website. Items may […]

Endorsing SSP Using the New Dispenser Endorsement

For the purposes of the guidance, the scenarios below are test examples. You must always refer to the latest SSP information. Background Serious Shortage Protocols (SSPs) are an exemption to regulation 214 of the Human Medicines Regulations 2012, which allow pharmacies to manage serious shortages of medicines. Once an SSP has been issued by the […]

Dispensing Colecalciferol 1,000units/ml oral drops sugar free

Please note there has been a change on NHSBSA dm+d browser for the listing of Colecalciferol 1,000units/ml oral drops sugar free. The concept for 1,000units/ml strength has been discontinued and replaced by Colecalciferol 1,000units/drop oral drops sugar free. There will no longer be an option to select 1,000units/ml strength from the ‘Select prescribed item’ screen on ProScript Connect and for electronic prescriptions the product will […]

Update to FMD Regulations

The UK FMD Working Group has issued an update for Healthcare Professionals involved with FMD across the UK. Now that the UK has left the EU and the Transition Period ends on 31st December 2020, some regulatory requirements will no longer apply. However, certain EU legislation will continue to have effect in Northern Ireland under the Northern Ireland Protocol […]

Serious Shortage Protocols (SSP) Declaration Guidance

From October 2021 contractors must endorse the number of SSP claims made each month on the FP34C form. This declaration will not be used for reimbursement but to indicate SSP claim(s) were made in the month. Please note this is a declaration of the claims and not the number of items dispensed in accordance with […]

Dispensing Venlafaxine oral solution sugar free

Licensed products by Rosemont are now available for both Venlafaxine 37.5mg/5ml oral solution sugar free and Venlafaxine 75mg/5ml oral solution sugar free. In order to be reimbursed correctly for the product that you have dispensed, the following guidance should be followed. Paper Prescriptions In order to dispense and be reimbursed for the licensed product, the […]

Hypertension Case Finding Service

The Hypertension case finding service has been commissioned as an Advanced service from 1st October 2021. The service involves identifying people aged 40 years or older with high blood pressure, who have previously not had a confirmed diagnosis of hypertension, and to refer them to general practice to confirm diagnosis and for appropriate management. Further information […]

CPCF 2021/2022

CPCF 2021/2022 Details for the Pharmacy Quality Scheme (PQS) which forms part of the Community Pharmacy Contractual Framework (CPCF) have been published. This page contains information to help assist pharmacy contractors in England to meet the requirements of the CPCF through ProScript Connect (PSC). Further information can be found on the PSNC website. Respiratory Domain Return […]

NMS Expansion: September 2021

NMS Expansion: September 2021 Background From 1st September 2021, contractors can provide the New Medicines Service (NMS) to patients that are newly prescribed medicines for the following additional conditions: Acute coronary syndrome (ACS); Atrial fibrillation (AF); Coronary heart disease; Epilepsy; Glaucoma; Gout; Heart failure; Hypercholesterolaemia ; Long term risks of venous thromboembolism/embolism; Osteoporosis; Parkinson’s Disease; Stroke / […]

*NEW*Quality and Safety Scheme (Wales)

Dear Pharmacist As part of the Quality and Safety Scheme, pharmacies are required to complete a High Risk Medicines information survey. This involves providing information on the number of patients whose prescriptions were dispensed in the pharmacy during a specified time period based on certain conditions outlined in the link below: http://www.cpwales.org.uk/Services-and-commissioning/Quality-Scheme/High-Risk-Medicines-Survey-2021-22.aspx Quality and Safety […]

*Updated* Important Message – Changes to SNOMED concept IDs

Dear Pharmacist, The NHS Business Services Authority have made changes to existing VMP SNOMED codes which are used for electronic prescribing. Due to the code changes, some prescribing systems may still be issuing electronic prescriptions using the inactive VMP SNOMED codes in the near future. What this means is that any affected products will not […]

EPS Phase 4 now live

EPS Phase 4 now live All dispensers need to be aware that they could now receive an EPS Phase 4 token from a patient. GP practices can now use EPS for patients without a nomination, with patients receiving a Phase 4 token with a scannable barcode instead of a signed FP10. All four GP system […]